AEROVATE THERAPEUTICS INC. - COMMON STOCK
2.5600
14-November-24 16:45:00
15 minutes delayed
Stocks
-0.0700
-2.66%
Today's range
2.5450 - 2.6350
ISIN
N/A
Source
NASDAQ
-
Aerovate Therapeutics to Explore Strategic Alternatives
08 Jul 2024 08:00:00 By Nasdaq GlobeNewswire
-
17 Jun 2024 08:32:00 By Nasdaq GlobeNewswire
-
21 May 2024 16:15:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
13 May 2024 16:30:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
25 Mar 2024 16:10:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
06 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
13 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Announces Second Quarter Financial Results and Business Highlights
14 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors
11 Jul 2023 17:00:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics to Present at Jefferies Global Healthcare Conference
01 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
15 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Announces Full-Year 2022 Financial Results and Business Highlights
29 Mar 2023 16:50:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics to Present at Cowen 43rd Annual Health Care Conference
02 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Appoints Donald Santel To Its Board of Directors
23 Jan 2023 08:00:00 By Nasdaq GlobeNewswire
-
17 Nov 2022 07:45:00 By Nasdaq GlobeNewswire
-
Aerovate Therapeutics Announces Third Quarter 2022 Financial Results
14 Nov 2022 07:45:00 By Nasdaq GlobeNewswire
-
18 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >